Date stringdate 2012-01-01 00:00:00 2023-12-31 00:00:00 | Stock_symbol stringlengths 1 5 | Article_title stringlengths 1 255 | Article stringlengths 1 342k |
|---|---|---|---|
2022-06-01 00:00:00+00:00 | ABBV | AbbVie Presents Positive Results From Phase 3 Trials Of Upadacitinib In Axial Spondyloarthritis | (RTTNews) - AbbVie (ABBV) said that it presented full results from two studies from the Phase 3 SELECT-AXIS 2 program evaluating upadacitinib (RINVOQ), an oral therapy, in adult patients with active non-radiographic axial spondyloarthritis or nr-axSpA and patients with treatment-refractory active ankylosing spondylitis... |
2022-06-01 00:00:00+00:00 | ABBV | 1 Green Flag for AbbVie in 2022 and 1 Red Flag | If there was one area of optimism in this market since the start of the year, I'd have to say it was healthcare. The S&P 500 healthcare sector grew 2.7% -- until the first week of April hit. Then the bottom dropped out. Yet, year-to-date the healthcare sector is still down only 6% in 2022 vs. a 13.5% decline for the br... |
2022-06-01 00:00:00+00:00 | ABBV | My 3 Favorite Dividend Stocks to Buy in June | Forget the old adage "sell and May and go away." Any time is a good time to buy dividend stocks. That's true even when the stock market is highly volatile -- as it is now.
There are two important prerequisites, though. First, you need to have a long-term mindset. Even the best dividend stocks can fall over the short te... |
2022-05-30 00:00:00+00:00 | ABBV | The 3 Best Performing ETFs Money Can Buy in 2022 | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
These best performing ETFs so far this year could see further traction as investors return to the markets.
First Trust Morningstar Dividend Leaders Index Fund (FDL): This ETF focuses on dividend growth consistency when choosing stocks.
WisdomTree U.S. High ... |
2022-05-27 00:00:00+00:00 | ABBV | Noteworthy Friday Option Activity: QCOM, MCD, ABBV | Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Qualcomm Inc (Symbol: QCOM), where a total volume of 43,535 contracts has been traded thus far today, a contract volume which is representative of approximately 4.4 million underlying shares (given that ever... |
2022-05-27 00:00:00+00:00 | ABBV | HDV, YCS: Big ETF Inflows | Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the iShares Core High Dividend ETF, which added 19,800,000 units, or a 20.2% increase week over week. Among the largest underlying components of HDV, in morning trading today Exxon Mobil is tr... |
2022-05-26 00:00:00+00:00 | ABBV | SPY, ABBV, ABT, ACN: ETF Inflow Alert | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P 500 ETF Trust (Symbol: SPY) where we have detected an approximate $1 inflow -- that's a 0.3% increase week over week in outstanding units (from 90,0,8,80,,000 to 90,3,9,80,,000). Am... |
2022-05-26 00:00:00+00:00 | ABBV | Best Health Care Stocks To Invest In 2022? 3 Names To Watch | Are These The Best Health Care Stocks To Have On Your June 2022 Watchlist?
As talks of inflation and a possible recession dominate the headlines, investors may choose to rotate towards more defensive positions. Hence, health care stocks could be worth looking at. After all, health care stocks encompass a broad range of... |
2022-05-26 00:00:00+00:00 | ABBV | Amgen (AMGN) Ahead of Industry This Year So Far: What's Next? | Amgen has a diverse and growing portfolio of medicines in large therapeutic categories that it expects will help it drive growth through the end of the decade despite a declining pricing environment.
Amgen AMGN stock has risen 12.4% this year so far against a decrease of 24.5% for the industry.
Image Source: Zacks Inv... |
2022-05-26 00:00:00+00:00 | ABBV | 7 High-Yield Retirement Stocks to Buy for Your Nest Egg | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
These seven high-yield retirement stocks to buy are among the top picks to build a retirement portfolio that will provide a stable income.
Amcor (AMCR): Is a global leader in developing and producing responsible packaging.
3M Company (MMM): This conglomerat... |
2022-05-26 00:00:00+00:00 | ABBV | 3 Healthcare Stocks You Can Buy and Hold for the Next Decade | It's exciting to add new stocks to your portfolio or adjust positions. But it's also nice to own a handful of stocks that you can buy and hold on to for a long time -- like a decade or longer. You know that you can count on them for leadership in their market and earnings growth. Eventually, that should translate into ... |
2022-05-25 00:00:00+00:00 | ABBV | SpringWorks (SWTX) Down Despite Desmoid Tumors Study Meeting Goal | SpringWorks Therapeutics, Inc. SWTX announced the phase III DeFi study, which evaluated its investigational gamma-secretase inhibitor, nirogacestat, for treating adult patients with progressing desmoid tumors, has met the primary and all key secondary endpoints.
Data from the study showed that treatment with nirogacest... |
2022-05-25 00:00:00+00:00 | ABBV | 2 Dividend Kings That Are Soundly Beating the Market in 2022 | Are you not sure about where to invest right now? Dividend stocks can be a great place to start looking. Their financials are generally sound, and they can enable you to collect some recurring cash flow while you hang on to your investment. And at a time when investors have been looking for safety, some of them have al... |
2022-05-25 00:00:00+00:00 | ABBV | Teva, Allergan reach $161.5 million opioid settlement with West Virginia | By Dietrich Knauth
May 25 (Reuters) - Teva Pharmaceutical Industries TEVA.TA and AbbVie's ABBV.N Allergan unit reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, state attorney general Patrick Morrisey said Wednesday.
The agreement is the largest state-... |
2022-05-25 00:00:00+00:00 | ABBV | 7 Retirement Stocks to Buy to Turbocharge Your Savings | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Buying quality retirement stocks can provide both safety and growth to keep savings goals on track
AbbVie (ABBV): With revenue concerns abating, it’s time to take a fresh look at this dividend king.
Amgen (AMGN): This biotech giant has an ideal combination ... |
2022-05-24 00:00:00+00:00 | ABBV | 3 Great Dividend Stocks to Buy Now and Hold | Today’s episode of Full Court Finance at Zacks breaks down the broader economic forces behind the current market turmoil. The episode then explores three strong dividend-paying stocks from three different areas of the economy that investors might want to consider buying during the market downturn and holding for the lo... |
2022-05-24 00:00:00+00:00 | ABBV | Why High Dividend ETFs are Beating the Market | Dividend paying stocks are always popular with investors since about a third of S&P 500’s total returns since 1960 can be attributed to dividends. Over the past three decades, S&P 500 returns including dividends exceeded the index’s price returns by more than double, per BlackRock.
In the current market environment of ... |
2022-05-24 00:00:00+00:00 | ABBV | These 2 Numbers Could Spell Trouble for AbbVie Stock | AbbVie (NYSE: ABBV) investors might have a reason to start sweating. After a somewhat weak first quarter, the biopharma company's near future looks like it'll be one with a bit less revenue than expected.
That's something that would always be a problem, but in this case, the issue is a bit more pressing than usual. Bef... |
2022-05-23 00:00:00+00:00 | ABBV | AbbVie (ABBV) Files NDA for Parkinson's Disease Candidate | AbbVie Inc. ABBV submitted a new drug application (“NDA”) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in patients with advanced Parkinson's disease (PD) to the FDA.
The regulatory filing was based on data from a phase III head-to-head study, which showed that treatment with ABBV-951 ... |
2022-05-23 00:00:00+00:00 | ABBV | AbbVie:CHMP Recommends European Commission Approval Of Upadacitinib For Ulcerative Colitis Treatment | (RTTNews) - The European Medicines Agency's or EMA Committee for Medicinal Products for Human Use or CHMP adopted a positive opinion recommending the approval of upadacitinib (RINVOQ, 45 mg [induction dose] and 15 mg and 30 mg [maintenance dose]) for the treatment of adult patients with moderately to severely active ul... |
2022-05-21 00:00:00+00:00 | ABBV | 7 Quality Dividend Stocks to Buy on the Dip | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
In the current market evironment, investors could find solid ground with this dividend stocks to buy.
Merck (MRK): Robust results across its core portfolio, with its oncology portfolio expected to fire on all cylinders.
Chevron (CVX): Cash flow generating m... |
2022-05-21 00:00:00+00:00 | ABBV | 7 Retirement Stocks to Buy for Any Market Conditions | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Although the market turmoil may have investors scrambling for cover, these retirement stocks can likely withstand the heat.
Brookfield Infrastructure (BIPC): One of the largest owners and operators of critical global infrastructure networks, Brookfield pres... |
2022-05-20 00:00:00+00:00 | ABBV | Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know | AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Shares of this drugmaker have returned -4.3% over the past month versus the Zacks S&P 500 composite's -12.5% cha... |
2022-05-20 00:00:00+00:00 | ABBV | Pharma Stock Roundup: FDA Nod to PFE COVID Jab for Age 5-11 & LLY's Tirzepatide | This week, the FDA granted emergency authorization to booster shots of Pfizer PFE/BioNTech’s COVID-19 vaccine for use in children 5 to 11 years of age and also approved Lilly’s LLY novel diabetes treatment, Mounjaro (tirzepatide) injection. AbbVie ABBV and AstraZeneca AZN announced new licensing deals with small privat... |
2022-05-20 00:00:00+00:00 | ABBV | AbbVie Submits NDA For ABBV-951 To FDA For Treatment Of Advanced Parkinson's Disease | (RTTNews) - Biopharmaceutical company AbbVie Inc. (ABBV) announced Friday that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in patients with advanced Parkinson's disease (PD).
The submission i... |
2022-05-19 00:00:00+00:00 | ABBV | These 3 Stocks Have Doubled Over the Past 3 Years. Can They Do It Again? | Carlisle Companies (NYSE: CSL), Innovative Industrial Properties (NYSE: IIPR) and AbbVie (NYSE: ABBV) have all seen shares double over the past three years. All three have the potential to double their shares again over the next three years because of their stability, consistent revenue growth, and attractive dividends... |
2022-05-18 00:00:00+00:00 | ABBV | 7 Best Value Stocks to Buy if You Need Some Market Stability in Your Life | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Weakness and long-term fear make investing in value stocks a strong idea right now.
Target (TGT): Earnings have been strong and Target is fundamentally strong.
D.R. Horton (DHI): Forces are in place for this home builder to continue to perform very well.
... |
2022-05-18 00:00:00+00:00 | ABBV | Vertex (VRTX) Outperforms Industry This Year So Far: Here's Why | Vertex Pharmaceuticals Incorporated VRTX stock has risen 19.2% this year so far against the industry’s decline of 25%.
Image Source: Zacks Investment Research
Vertex’s main area of focus is cystic fibrosis (CF). With its four CF medicines, Vertex is treating the majority of the 83,000 patients living with CF in the Un... |
2022-05-17 00:00:00+00:00 | ABBV | Is It Too Late to Buy AbbVie Stock? | Pharma giant AbbVie (NYSE: ABBV) has rewarded shareholders in the past decade with market-beating performance. That is especially noteworthy considering many pharma companies struggled through much of the 2010s as evidenced by the fact that the SPDR S&P Pharmaceutical ETF -- an industry benchmark -- substantially lagge... |
2022-05-17 00:00:00+00:00 | ABBV | AbbVie (ABBV) Buys Option Rights to NextGen Inflammation Drug | AbbVie ABBV announced that it signed a deal with precision medicines biotech, Cugene, for CUG252, a potential best-in-class Treg-selective IL-2 mutein for the potential treatment of autoimmune and inflammatory diseases.
Per the deal, AbbVie will get an option to license worldwide rights for certain IL-2 muteins, includ... |
2022-05-16 00:00:00+00:00 | ABBV | Japan pharma lobbies say pricing scheme leading to renewed 'drug lag' | TOKYO, May 16 (Reuters) - Japan's three major pharmaceutical lobbies joined for the first time on Monday in urging reforms to the government's drug-pricing system to avoid losing out on investment and new drugs.
While American and European drugmakers have complained for years about drug prices set by Japan's socialised... |
2022-05-16 00:00:00+00:00 | ABBV | 3 Dividend Stocks That Should Pay You for the Rest of Your Life | If you've got some cash stored up, consider yourself a wise investor -- and fortunate. Now could be a great time to put that cash to use toward an investment in these three Dividend Kings that could provide robust returns for a lifetime.
Shares of AbbVie (NYSE: ABBV), Lowe's (NYSE: LOW), and Parker Hannifin (NYSE: PH) ... |
2022-05-16 00:00:00+00:00 | ABBV | Buffett's Berkshire buys Citigroup and several other stocks, slashes Verizon | By Jonathan Stempel
May 16 (Reuters) - Berkshire Hathaway Inc BRKa.N on Monday said it added new investments in Citigroup Inc C.N and several other companies in the first quarter, as Warren Buffett's conglomerate took advantage of volatile stock markets to invest $51.1 billion that had largely been sitting in cash.
In ... |
2022-05-16 00:00:00+00:00 | ABBV | 7 Retirement Stocks for Steady Long-Term Income Growth | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
As economic troubles loom, these retirement stocks should keep you in the black.
AbbVie (ABBV): strong portfolio for sustained dividend growth.
ASE Technology Holding (ASX): semiconductor demand from automotive tailwinds.
BCE (BCE): effective cost managemen... |
2022-05-16 00:00:00+00:00 | ABBV | The 5 Best Dividend Stocks to Buy Now | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Investors are shopping around for the best dividend stocks that could help weather an uncertain stock market.
Abbvie (ABBV): Anticipates its newer drugs, Skyrizi and Rinvoq, to generate a combined revenue of over $15 billion in 2025.
Exxon Mobil (XOM): Trip... |
2022-05-14 00:00:00+00:00 | ABBV | 3 Supercharged Dividend Stocks to Buy in the Stock Market Sell-Off | Stock market crashes and corrections happen. Since the beginning of the year, the S&P 500 has been down over 17%. In fact, since the end of World War II, the benchmark index has tumbled more than 10% around 30 separate times.
A bear market of at least a 20% decline will also eventually happen again, maybe even this mon... |
2022-05-13 00:00:00+00:00 | ABBV | Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 Earnings Update | This week, Pfizer PFE offered to buy migraine drugmaker, Biohaven Pharmaceuticals for $11.6 billion. Bayer BAYRY announced first-quarter 2022 earnings. Roche RHHBY announced disappointing data from a phase III PD-L1-high metastatic non-small cell lung cancer (NSCLC)study. The FDA granted full approval to Eli Lilly LLY ... |
2022-05-13 00:00:00+00:00 | ABBV | 1 Company Disrupting Plastic Surgery, Not Patients | In a world where the word "selfie" translates into every language, more and more people want to look their best -- preferably without surgery. InMode (NASDAQ: INMD) is riding the wave of safer and faster results for patients, with industry-leading minimal and non-invasive RF technology that displaces painful liposuctio... |
2022-05-13 00:00:00+00:00 | ABBV | 3 Dividend Stocks You Can Buy and Hold for Decades | You've probably heard the phrase "Think long term" quite a bit if you've been an investor for a while. But what time frame qualifies as a long-term horizon? There's no magic number, but 10 years seems to be a good minimum threshold.
However, there are some stocks with such strong underlying businesses that even 10 year... |
2022-05-12 00:00:00+00:00 | ABBV | July 1st Options Now Available For AbbVie | Investors in AbbVie Inc (Symbol: ABBV) saw new options begin trading today, for the July 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new July 1st contracts and identified one put and one call contract of particular interest.
The put contract at ... |
2022-05-12 00:00:00+00:00 | ABBV | Pharma Stocks: The Perfect Cure in an Unhealthy Environment? | The COVID-19 pandemic resulted in several pharmaceutical companies profiting handsomely with robust sales from COVID-19 vaccines. This has also resulted in pharma companies faring relatively better in the stock market vis-à-vis other sectors, even amid the current market volatility. While pharma stocks like Pfizer have... |
2022-05-12 00:00:00+00:00 | ABBV | Lilly's (LLY) Olumiant Gets Full Approval From FDA for COVID | Eli Lilly and Company LLY and partner Incyte INCY announced that the FDA has granted full approval to their JAK inhibitor, Olumiant (baricitinib) for treating COVID-19 in certain hospitalized adults requiring various degrees of oxygen support.
Lilly and Incyte’s Olumiant has been available in the United States for trea... |
2022-05-11 00:00:00+00:00 | ABBV | AbbVie Announces Positive Topline Results From U-ENDURE Phase 3 Study Evaluating Upadacitinib | (RTTNews) - Biopharmaceutical company AbbVie Inc. (ABBV) announced on Wednesday positive topline results from U-ENDURE, its Phase 3 maintenance study evaluating upadacitinib in adult patients with moderate to severe Crohn's disease who had an inadequate response or were intolerant to a conventional or biologic therapy.... |
2022-05-11 00:00:00+00:00 | ABBV | The Zacks Analyst Blog Highlights AbbVie, Qualcomm, Linde, CVS Health Corp, and Booking Holdings | For Immediate Release
Chicago, IL – May 11, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: AbbVie Inc. ABBV, Qualcomm Inc... |
2022-05-11 00:00:00+00:00 | ABBV | Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar? | If you're interested in broad exposure to the Large Cap Value segment of the US equity market, look no further than the First Trust Morningstar Dividend Leaders ETF (FDL), a passively managed exchange traded fund launched on 03/09/2006.
The fund is sponsored by First Trust Advisors. It has amassed assets over $2.43 bil... |
2022-05-10 00:00:00+00:00 | ABBV | Noteworthy ETF Outflows: SPY, AAPL, MSFT, ABBV | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P 500 ETF Trust (Symbol: SPY) where we have detected an approximate $2.4 billion dollar outflow -- that's a 0.7% decrease week over week (from 904,580,000 to 898,630,000). Among the l... |
2022-05-10 00:00:00+00:00 | ABBV | Q1 Earnings Scorecard and Analyst Reports for AbbVie, QUALCOMM & Linde | Tuesday, May 10, 2022
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features update on the 2022 Q1 earnings season and new research reports on 16 major stocks, including AbbVie Inc. (ABBV), QUALCOMM Incorporated (QCOM), and Linde plc (LIN). These research repor... |
2022-05-10 00:00:00+00:00 | ABBV | Reata (RETA) Q1 Earnings Top, Omaveloxolone MAA Likely in Q4 | Reata Pharmaceuticals, Inc. RETA reported first-quarter 2022 loss of $2.03 per share, narrower than the Zacks Consensus Estimate of a loss of $2.26.
However, the above loss included stock-based compensation and a non-cash interest expense. Adjusted loss for the quarter was $1.33 per share, wider than the loss of $1.16 ... |
2022-05-10 00:00:00+00:00 | ABBV | 6 Undervalued Stocks You Should Buy For the Long Term | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
These are the 6 undervalued stocks you should buy for the long term that have low price-to-earnings (P/E) multiples, pay good dividends, and also have share buyback programs.
McDonald’s (MCD): McDonald’s trades with a 2.23% dividend yield, 25x forward earni... |
2022-05-10 00:00:00+00:00 | ABBV | Walgreens, CVS, Walmart begin $878 million opioid trial in Ohio | By Dietrich Knauth
May 10 (Reuters) - CVS Health Corp CVS.N, Walgreens Boots Alliance Inc WBA.O and Walmart Inc WMT.N on Tuesday begin a first-of-its-kind trial to determine what the pharmacy chains owe for their role in the opioid epidemic in two Ohio counties, which are seeking $878 million.
A federal jury decided in... |
2022-05-06 00:00:00+00:00 | ABBV | Ironwood (IRWD) Q1 Earnings Miss, Linzess Growth Continues | Ironwood Pharmaceuticals, Inc. IRWD reported first-quarter 2022 adjusted earnings of 21 cents per share, missing the Zacks Consensus Estimate of 27 cents. The company had reported adjusted earnings of 24 cents per share in the year-ago quarter.
Total revenues of $97.5 million beat the Zacks Consensus Estimate of $95.49... |
2022-05-06 00:00:00+00:00 | ABBV | 7 Defensive Dividend Healthcare Stocks to Buy Now | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Adding defensive healthcare stocks can be a great way to ride out continued volatility in the market.
AbbVie (ABBV): Investors are overreacting to this venerable big pharma company’s recent earnings report.
Amgen (AMGN): An established biotech company with ... |
2022-05-05 00:00:00+00:00 | ABBV | June 24th Options Now Available For AbbVie (ABBV) | Investors in AbbVie Inc (Symbol: ABBV) saw new options begin trading today, for the June 24th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new June 24th contracts and identified one put and one call contract of particular interest.
The put contract a... |
2022-05-05 00:00:00+00:00 | ABBV | Walgreens reaches $683 mln opioid settlement with Florida | By Dietrich Knauth
May 5 (Reuters) - Walgreens Boots Alliance WBA.O said on Thursday it has reached a $683 million settlement with Florida to resolve claims that the pharmacy chain exacerbated an opioid epidemic in the state.
The settlement includes $620 million to be paid to Florida over 18 years, plus $63 million for... |
2022-05-05 00:00:00+00:00 | ABBV | Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock | AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this drugmaker have returned -10.3%, compared to the Zacks S&P 500 composite's -6.1% change. Du... |
2022-05-05 00:00:00+00:00 | ABBV | 3 Top Healthcare Stocks to Buy for May | Investing in trends that are unlikely to reverse is key to being a successful investor.
A more populous and aging global population is almost a guarantee that quality healthcare stocks will do well over the long haul. That's because healthcare products and services are essential to extended life expectancies, which als... |
2022-05-05 00:00:00+00:00 | ABBV | Pfizer Is Poised to Shatter These 2 Records in 2022 | Pfizer (NYSE: PFE) just delivered the best quarter in the company's history. Its first-quarter revenue topped $25.6 billion. Adjusted profits totaled more than $9.3 billion.
The drugmaker isn't done yet. And it's likely to go beyond notching wins against its own historical performance. Pfizer is poised to shatter these... |
2022-05-05 00:00:00+00:00 | ABBV | This Stock Is Trouncing the Market in 2022 -- and Its Prospects Just Got Even Better | It's hard to swim against the current, and investors these days definitely find the current going against them. Most stocks have fallen, with the S&P 500 index in correction territory and the Nasdaq Composite index in bear territory again.
However, not every stock is being swept in the wrong direction. Here's one that'... |
2022-05-04 00:00:00+00:00 | ABBV | These Warren Buffett Dividend Stocks Can Make You $12,800 in Passive Income | If anyone knows that it takes money to make money, it's Warren Buffett. But the longtime Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO also knows that making significant passive income is actually easy if you have enough to invest in the right stocks.
Some great stock ideas can be found right in Berkshire's own po... |
2022-05-02 00:00:00+00:00 | ABBV | Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now? | Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trust Health Care AlphaDEX ETF (FXH) is a smart beta exchange traded fund launched on 05/08/2007.
What Are Smart Beta ETFs?
Market cap weighted indexes were created to reflect the market, or a specific segment of the market, an... |
2022-04-30 00:00:00+00:00 | ABBV | AbbVie's Q1 Good News That Investors Could Be Missing | The first-quarter results AbbVie (NYSE: ABBV) delivered before the market opened Friday were disappointing in several ways. The drugmaker's revenue of $13.5 billion undershot the consensus Wall Street estimate of $13.6 billion, and management also lowered its full-year adjusted earnings guidance.
The pharma stock slid ... |
2022-04-30 00:00:00+00:00 | ABBV | AbbVie (ABBV) Q1 2022 Earnings Call Transcript | Image source: The Motley Fool.
AbbVie (NYSE: ABBV)
Q1 2022 Earnings Call
Apr 29, 2022, 9:00 a.m. ET
Contents:
Prepared Remarks
Questions and Answers
Call Participants
Prepared Remarks:
Operator
Good morning, and thank you for standing by. Welcome to the AbbVie first quarter 2022earnings conference call [Operator instr... |
2022-04-30 00:00:00+00:00 | ABBV | FDA Approves AbbVie's Rinvoq To Treatment Active Ankylosing Spondylitis | (RTTNews) - The U.S. Food and Drug Administration has approved AbbVie's (ABBV) Rinvoq (upadacitinib; 15 mg, once daily) for the treatment of adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more tumor necrosis factor blockers.
The FDA approval was supported by effic... |
2022-04-29 00:00:00+00:00 | ABBV | AbbVie Shares Hurt On Reduced Earnings Outlook | (RTTNews) - Shares of biopharmaceutical company AbbVie Inc. (ABBV) are down more than 8% after the company reduced its annual earnings outlook. Its first-quarter sales also missed analysts' view.
The company cut its annual EPS outlook to $13.92 - $14.12 from $14.00 - $14.20 citing a $0.08 per share impact related to th... |
2022-04-29 00:00:00+00:00 | ABBV | Why AbbVie's Shares Dropped 10.5% Friday | What happened
Pharmaceutical company AbbVie (NYSE: ABBV) saw its shares drop 10.5% on Friday. The stock closed at $156.31 on Thursday, then opened on Friday at $149.56 and fell to a low of $139.93 in early morning trading before rallying a bit in the afternoon.
The stock's 52-week low is $105.56 with a 52-week high of ... |
2022-04-29 00:00:00+00:00 | ABBV | Health Care Sector Update for 04/29/2022: RMD,ABBV,FNCH,ZYME | Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking 2.0% and the SPDR Health Care Select Sector ETF (XLV) down 2.1%.
The Nasdaq Biotechnology index was retreating 1.7%.
In company news, ResMed (RMD) slipped 6.3% after the medical devices company overnight reported non-GAAP net i... |
2022-04-29 00:00:00+00:00 | ABBV | Notable Friday Option Activity: ABBV, CBOE, EXPE | Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in AbbVie Inc (Symbol: ABBV), where a total of 59,816 contracts have traded so far, representing approximately 6.0 million underlying shares. That amounts to about 73.7% of ABBV's average daily trading volume over the p... |
2022-04-29 00:00:00+00:00 | ABBV | Technology Sector Update for 04/29/2022: ABBV,FNCH,ZYME | Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking 1.7% and the SPDR Health Care Select Sector ETF (XLV) down 1.9%.
The Nasdaq Biotechnology index was retreating 0.8%.
In company news, AbbVie (ABBV) dropped 8.7% after the drugmaker cut its FY22 earnings outlook by $0.08 per sha... |
2022-04-29 00:00:00+00:00 | ABBV | Health Care Sector Update for 04/29/2022: LNTH, NVO, ABBV, XLV, IBB | Health care stocks were mixed premarket Friday. The Health Care SPDR (XLV) was down 0.83%, and the iShares NASDAQ Biotechnology Index (IBB) was recently inactive.
Lantheus Holdings (LNTH) was gaining more than 16% after it reported Q1 adjusted earnings of $0.97 per diluted share, up from $0.05 a year earlier. Four anal... |
2022-04-29 00:00:00+00:00 | ABBV | AbbVie misses quarterly sales expectations on Humira competition | By Manas Mishra
April 29 (Reuters) - AbbVie Inc ABBV.N missed Wall Street estimates for first-quarter sales on Friday, hurt by European competition for its blockbuster rheumatoid arthritis drug Humira and lower-than-expected revenue from its newer drug Rinvoq.
Shares of Illinois-based Abbvie fell 4.3% to $159.30 before... |
2022-04-29 00:00:00+00:00 | ABBV | AbbVie (ABBV) Tops Q1 Earnings Estimates | AbbVie (ABBV) came out with quarterly earnings of $3.16 per share, beating the Zacks Consensus Estimate of $3.15 per share. This compares to earnings of $2.95 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 0.32%. A quarter ago, it was e... |
2022-04-29 00:00:00+00:00 | ABBV | AbbVie Q1 Income Rises | (RTTNews) - AbbVie (ABBV) released a profit for its first quarter that increased from the same period last year
The company's earnings totaled $4.49 billion, or $2.51 per share. This compares with $3.55 billion, or $1.99 per share, in last year's first quarter.
Excluding items, AbbVie reported adjusted earnings of $5.6... |
2022-04-29 00:00:00+00:00 | ABBV | AbbVie Trims FY22 Adj. EPS Outlook - Update | (RTTNews) - While reporting financial results for the first quarter on Friday, biopharmaceutical company AbbVie Inc. (ABBV) trimmed its adjusted earnings guidance for the full-year 2022.
For fiscal 2022, AbbVie now projects adjusted earnings in a range of $13.92 to $14.12 per share, which includes an unfavorable impact... |
2022-04-29 00:00:00+00:00 | ABBV | AbbVie misses quarterly sales estimates as Humira rivals bite | April 29 (Reuters) - AbbVie Inc ABBV.N missed Wall Street estimates for first-quarter sales on Friday, hurt by European competition for its blockbuster rheumatoid arthritis drug Humira and lower-than-expected revenue from its newer drug Rinvoq.
Sales of the world's best selling drug, Humira, fell 2.7% to $4.74 billion ... |
2022-04-29 00:00:00+00:00 | ABBV | The 3 Best ETFs for Dividends | If you're wishing you had a little more exposure to income investments right now and a little less exposure to growth, you're not alone. The market's recent shellacking hasn't exactly been uniform; growth stocks have really taken it on the chin. And their sell-off may not be over yet.
The good news is, it's not too lat... |
2022-04-28 00:00:00+00:00 | ABBV | XRP vs. AbbVie: Price Relationship Crosses Threshold | Here at CryptocurrenciesChannel.com, we find it interesting to track various ETF and stock prices versus various digital assets over time.
We noticed that as of 4/28/2022, XRP ($XRP) can buy you the least amount of AbbVie shares, in the past year. For example, if you had 100 XRP coins and wished to buy shares of ABBV(S... |
2022-04-28 00:00:00+00:00 | ABBV | Pre-Market Earnings Report for April 29, 2022 : XOM, CVX, ABBV, AZN, BMY, HON, CHTR, CL, AON, TRP, PSX, LYB | The following companies are expected to report earnings prior to market open on 04/29/2022. Visit our Earnings Calendar for a full list of expected earnings releases.
Exxon Mobil Corporation (XOM)is reporting for the quarter ending March 31, 2022. The oil company's consensus earnings per share forecast from the 7 anal... |
2022-04-28 00:00:00+00:00 | ABBV | Drug/Biotech Stocks Q1 Earnings Due on Apr 29: BMY, ABBV, AZN | First-quarter earnings kick-started last week for the pharma/biotech sector. A few pharma bigwigs have reported so far, along with a few biotech players. Several are scheduled to report shortly. Bellwether Johnson & Johnson JNJ reported mixed results, beating on earnings but missing revenue estimates. Swiss major Nova... |
2022-04-28 00:00:00+00:00 | ABBV | 7 A-Rated Dividend Stocks to Buy Forever | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Quality dividend stocks like these can see portfolios through good times and bad. Buy these and hold them forever.
AbbVie (ABBV): 3.64% forward yield. The market is overreacting to recent news with this pharmaceutical giant.
Best Buy (BBY): 3.86% forward yi... |
2022-04-28 00:00:00+00:00 | ABBV | Eli Lilly (LLY) Q1 Earnings and Revenues Top Estimates | Eli Lilly (LLY) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.32 per share. This compares to earnings of $1.87 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 12.93%. A quarter ago, it wa... |
2022-04-28 00:00:00+00:00 | ABBV | Why Earnings Season Could Be Great for AbbVie (ABBV) | Investors are always looking for stocks that are poised to beat at earnings season and AbbVie Inc. ABBV may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
That is because AbbVie is seeing favorable earnings estimate revision activity as of lat... |
2022-04-27 00:00:00+00:00 | ABBV | 3 Small-Cap Medical Stocks With Big Momentum | Rengenxbio (NASDAQ: RGNX), Corcept Therapeutics (NASDAQ: CORT), and Pacira BioSciences (NASDAQ: PCRX) are all small-cap healthcare stocks with market caps below $3.5 billion. While the share prices of many companies in this sector have plummeted recently, these three have risen in the past three months.
That said, they... |
2022-04-27 00:00:00+00:00 | ABBV | AbbVie: Health Canada Approves VRAYLAR - Quick Facts | (RTTNews) - AbbVie (ABBV) said Health Canada has approved VRAYLAR (cariprazine) as monotherapy for the acute management of manic, mixed, and depressive episodes associated with bipolar l disorder in adults, and the treatment of schizophrenia in adults. VRAYLAR is a new atypical antipsychotic medication with partial ago... |
2022-04-27 00:00:00+00:00 | ABBV | Will Biogen (BIIB) Succeed in Beating Q1 Earnings Estimates? | We expect Biogen BIIB to beat expectations when it reports first-quarter 2022 results on May 3, before market open. In the last reported quarter, the company delivered an earnings surprise of 2.11%.
The company’s earnings beat estimates in each of the last four quarters. The company has a four-quarter earnings surprise... |
2022-04-26 00:00:00+00:00 | ABBV | AbbVie: What to Expect from Q1 Earnings | Shares of biopharma company AbbVie (NYSE: ABBV) have surged 15.5% year-to-date, outperforming the broader market. Amid the volatility, many investors prefer safer bets like AbbVie, which offers an attractive dividend yield.
AbbVie’s dividend yield stands at 3.49%, ahead of the healthcare sector’s average dividend yield... |
2022-04-26 00:00:00+00:00 | ABBV | Universal Health (UHS) Q1 Earnings Miss Mark, Tumble Y/Y | Universal Health Services, Inc. UHS reported first-quarter 2022 adjusted earnings of $2.15 per share, which missed the Zacks Consensus Estimate of $2.47 by 13%. The bottom line decreased 11.9% year over year.
Results were hurt by escalating expenses and lower admissions in its Behavioral Health Care Services segment. ... |
2022-04-26 00:00:00+00:00 | ABBV | Healthcare ETFs in Focus Ahead of Q1 Earnings | The healthcare sector has gained some momentum lately on investors’ rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfolio. Additionally, lockdown measures in China have led to global growth concerns, thereby raising the appeal for defensi... |
2022-04-26 00:00:00+00:00 | ABBV | Walgreens, drugmakers blame others for San Francisco's opioid crisis | By Dietrich Knauth
April 26 (Reuters) - Pharmacy chain Walgreens Boots Alliance WBA.O and other defendants on Tuesday said they were not to blame for the opioid crisis in San Francisco, and that they acted responsibly when providing legal medications to patients in pain.
"Almost all of those prescriptions were written ... |
2022-04-26 00:00:00+00:00 | ABBV | 3 Dividend Stocks for Value Investors Seeking Regular Income | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
3M Company (MMM): This dividend stock has been paying dividends to its shareholders for more than 100 years.
AbbVie (ABBV): AbbVie has doubled its dividend over a span of seven years, after its spin-off from Abbot Laboratories.
Johnson & Johnson (JNJ): The... |
2022-04-26 00:00:00+00:00 | ABBV | 7 Retirement Stocks to Buy to Sleep Soundly at Night | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Kimberly Clark Corp (KMB) Kimberly-Clark produces many types of products, including diapers and feminine hygiene products. The company has delivered 50 consecutive years of dividend increases.
Lockheed Martin (LMT) Lockheed Martin is a company that has been... |
2022-04-26 00:00:00+00:00 | ABBV | What Stocks to Buy That Should Do Well in a Recession — Our 7 Top Picks | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
McDonald’s Corp (NYSE:MCD) — People eat fast food in a recession; pays a 2.21% yield with good dividend growth
Target (NYSE:TGT) — a growing retailer with good cash flow; pays a stable dividend with a 1.49% yield
Walmart (NYSE:WMT) — A discount retailer att... |
2022-04-26 00:00:00+00:00 | ABBV | Will Merck (MRK) Beat Expectations This Earnings Season? | We expect Merck MRK to beat expectations when it reports first-quarter 2022 results on Apr 28 before market open. In the last reported quarter, the company delivered an earnings surprise of 23.29%.
The large drugmaker’s performance has been mixed, with the company missing earnings expectations in two of the trailing fo... |
2022-04-25 00:00:00+00:00 | ABBV | AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know | In the latest trading session, AbbVie (ABBV) closed at $156.30, marking a +0.85% move from the previous day. This move outpaced the S&P 500's daily gain of 0.57%. Elsewhere, the Dow gained 0.7%, while the tech-heavy Nasdaq lost 0.1%.
Heading into today, shares of the drugmaker had lost 3.93% over the past month, laggin... |
2022-04-25 00:00:00+00:00 | ABBV | Walgreens, Teva accused of fueling opioid addiction in quest for new markets | By Dietrich Knauth
April 25 (Reuters) - Walgreens Boots Alliance WBA.O and Teva Pharmaceutical Industries Ltd TEVA.TA ignored the health risks when they created new markets for opioids, a lawyer for the city of San Francisco told a judge on Monday during opening statements of the first trial to target manufacturers, di... |
2022-04-25 00:00:00+00:00 | ABBV | Walgreens, Teva face San Francisco trial over opioid epidemic | By Dietrich Knauth
April 25 (Reuters) - San Francisco will square off on Monday against Walgreens Boots Alliance WBA.O and three other companies accused of fueling an opioid crisis in the city, the first trial to target manufacturers, distributors and pharmacies over the addictive pain medicines.
San Francisco has alle... |
2022-04-24 00:00:00+00:00 | ABBV | These Dividend Stocks Are Trouncing the Market -- Are They Still Buys? | Stocks are always going up. It's just not all of them that do so. But there are always outliers that rise even when the overall market is sinking.
With growth stocks out of favor, many investors have turned to big drugmakers and energy giants that pay attractive dividends. Here are three such dividend stocks that are t... |
2022-04-24 00:00:00+00:00 | ABBV | 3 Dividend Growth Titans to Increase Your Passive Income | At a time when inflation is skyrocketing, it's particularly hard for many people's salaries to keep up with their most basic costs. A great alternative approach to cover those costs, without having to work more or wait on tough-to-get raises, is to build a passive income stream through dividends.
With that in mind, we ... |
2022-04-23 00:00:00+00:00 | ABBV | 3 Dividend Stocks You Can Buy and Hold for Decades | Investors make the most money when they have more of a crockpot mentality than a microwave mentality. Buying and holding for the long term works -- when you pick the right stocks, of course.
We asked three Motley Fool contributors to identify dividend stocks that you can buy and hold for decades. Here's why they chose ... |
2022-04-22 00:00:00+00:00 | ABBV | AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release | Wall Street expects a year-over-year increase in earnings on higher revenues when AbbVie (ABBV) reports results for the quarter ended March 2022. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the act... |
2022-04-22 00:00:00+00:00 | ABBV | iShares Core High Dividend ETF Experiences Big Inflow | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core High Dividend ETF (Symbol: HDV) where we have detected an approximate $792.0 million dollar inflow -- that's a 8.5% increase week over week in outstanding units (from 85,550,000... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.